drugset / Trial / NCT05118906
Pilot Study on BP1.4979 Effect on Binge Eating Disorders
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This pilot study is to assess the efficacy and safety of BP1.4979 15 mg BID in female patients with moderate to severe binge eating disorder (BED), as defined according to DSM-5 guidelines.
Timeline
- Start
- 2022-03-07
- Primary completion
- 2025-08-14
- Completion
- 2025-08-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BP1.4979 | Small molecule | 15 mg | — |